Position in MNKD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,502,324
+$1,094,309 QoQ
Shares Held
587,400
+2.2% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 254 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. MNKD ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in MNKD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,502,324 | 587,400 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,408,015 | 574,700 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,258,549 | 574,700 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,006,663 | 559,900 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,062,610 | 551,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,687,529 | 534,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,477,987 | 540,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,343,135 | 531,500 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,760,858 | 528,900 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,395,917 | 528,900 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,925,196 | 528,900 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,399,530 | 581,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,341,471 | 575,300 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,212,770 | 539,700 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,110,881 | 590,300 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,758,210 | 569,000 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,150,364 | 564,400 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,076,992 | 564,400 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,279,392 | 521,600 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,268,960 | 521,600 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,842,720 | 521,600 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||